Product Name: Insight Base Flex - 8, Ref 608-3TX; The device consists of a sterile Snap that includes reflective features that facilitate imaging of the (attached) instrument using instrument tracking technology when used with a compatible tracking system. Each TrackX® Snap has a unique set of 2 or more reflective markers. By having unique configurations of reflective markers, it is possible to identify which TrackX Snap is in the field of view of the camera(s). As such, it is also possible to have multiple TrackX Snaps in the field at once and to have different TrackX Snaps for different surgical instruments. The device is considered to be a sterile accessory.
Publicado el 6 de noviembre de 2024 · Inicio del retiro: 3 de septiembre de 2024
Resumen
FDA registra el retiro Z-0260-2025 de dispositivos médicos de Clase III, publicado el 6 de noviembre de 2024 e iniciado el 3 de septiembre de 2024. Empresa responsable: Trackx Technology Inc; Estado: En curso; Cantidad reportada: 82; Lote: GTIN: 00857088008493, Lot: 2404002, Expiration Date: 04/01/2027. La Clase III indica que no es probable que el producto cause consecuencias adversas para la salud.
Estado reportado al momento de publicación: Ongoing — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
The patient label stickers may have the wrong expiration date recorded. The contract manufacturer entered the manufacturing date (2024-04-01) as the expiration date. The actual expiration date of the product is 2027-04-01. This is reflected on the carton label and sterile pouch label correctly.
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Trackx Technology Inc
- Distribuidor
- NC, VA, FL, PA, NY
- Lote
- GTIN: 00857088008493, Lot: 2404002, Expiration Date: 04/01/2027
- Clasificación de riesgo
- Class III
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDAOsom Ultra hCG Combo Test- IVD immunoassay for the qualitative detection of human chorionic gonadotropin (hCG)6 de noviembre de 2024
- FDAAmbu® VivaSight 2 DLT Endobronchial tube, 35 FR (Catalog Number 412351000), 37 Fr (Catalog Number 412371000),6 de noviembre de 2024
- FDA17-OH Progesterone ELISA 96 well kit- An enzyme immunoassay for the quantitative in vitro diagnostic6 de noviembre de 2024
- FDADuraform Dural Graft Implant, Size 3x3 , Model Number 80-1477US Lot CT0076946 de noviembre de 2024
- FDAChameleon PTA Balloon Catheter with Injection Port 5mm x 40mm x 75cm (CFN CH05-40-75US), 6mm x 40mm x 75cm6 de noviembre de 2024
- FDA1) Flex Extenders, 5.2" x 15mm OD x 15mm ID REF S6411P 2) Flex Extender, 5.2" x 15mm OD x 22/15mm ID REF 76 de noviembre de 2024
Preguntas sobre este retiro
¿Product Name: Insight Base Flex - 8, Ref 608-3TX; The device consists of a sterile Snap that includes reflective features that facilitate imaging of the (attached) instrument using instrument tracking technology when used with a compatible tracking system. Each TrackX® Snap has a unique set of 2 or more reflective markers. By having unique configurations of reflective markers, it is possible to identify which TrackX Snap is in the field of view of the camera(s). As such, it is also possible to have multiple TrackX Snaps in the field at once and to have different TrackX Snaps for different surgical instruments. The device is considered to be a sterile accessory. fue retirado del mercado?
Sí. FDA publicó el retiro Z-0260-2025 el 6 de noviembre de 2024. Peligro reportado: The patient label stickers may have the wrong expiration date recorded. The contract manufacturer entered the manufacturing date (2024-04-01) as the expiration date. The actual expiration date of the product is 2027-04-01. This is reflected on the carton label and sterile pouch label correctly.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter